{"symbol":"ABBV","fiscalQuarter":"Q2-2024","reportDate":"2024-07-25","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2024","postBrief":{"headline":"AbbVie Beats on EPS, Stock Up 3.38%","keyNumbers":[{"metric":"EPS","actual":"$2.65","expected":"N/A","surprise":"+3.03%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"AbbVie reported better-than-expected earnings per share, which led to a positive stock reaction, with shares rising by 3.38%. The lack of revenue data and management commentary leaves some uncertainty about the overall performance and future outlook. Investors may be encouraged by the EPS beat but will likely await further details in future reports.","metaDescription":"AbbVie Inc. (ABBV) Q2 2024 earnings: EPS beat by 3.03%. Stock up 3.38%. Full breakdown."}}